论文信息 - Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240 - 字舞流文

Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240

M. Kudo | A. Zhu | R. Finn | T. Yau | B. Daniele | Y. Chao | A. Cheng | M. Garrido | A. Siegel | S. Ogasawara | P. Merle | B. Ryoo | V. Breder | Ho Yeong Lim | M. Bouattour | J. Edeline | J. Norquist | E. Chen | A. Kulkarni | S. Chan